Matthieu Revest

Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey

Christine Selton‐Suty, M. Célard, Vincent Le Moing et al. · Clinical Infectious Diseases · 2012 · 698 citations

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative Patients

Pierre Fillâtre, Olivier Decaux, S. Jouneau et al. · The American Journal of Medicine · 2014 · 201 citations · Full text

Clinical Infectious Disease, Pneumocystis Jiroveci Pneumonia, Clinical Epidemiology +7

Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis

Lawrence P. Park, Vivian H. Chu, Gail Peterson et al. · Journal of the American Heart Association · 2016 · 199 citations · Full text

SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage

Florian Reizine, Mathieu Lesouhaitier, Murielle Grégoire et al. · Journal of Clinical Immunology · 2021 · 120 citations · Full text

Sars-cov-2-induced Ards Associates, Viral Persistence, Arginine Shortage +6